SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia

NCT02201134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-07-14

No results posted yet for this study

Summary

Studying the feasibility of an initial sedation with inhalated sevoflurane during therapeutic hypothermia of cardiac arrests resuscitated patients.

Conditions

  • Cardiac Arrest
  • Therapeutic Hypothermia

Interventions

DRUG

sevoflurane

Sponsors & Collaborators

  • University Hospital, Estaing

    collaborator OTHER
  • Hopital Gabriel Montpied

    collaborator OTHER
  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Sébastien PERBET · University Hospital, Clermont-Ferrand

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02201134 on ClinicalTrials.gov